Back
Rapt Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
RAPT
Rapt Therapeutics, Inc.
Last Price:
$57.71
Seasonality Move:
-39.76%
7 Day Trial
ALL ACCESS PASS
$
7
Rapt Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Rapt Therapeutics, Inc. has on average historically risen by 70.3% based on the past 6 years of stock performance.
-
Rapt Therapeutics, Inc. has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Rapt Therapeutics, Inc. Stock Undervalued?The current Rapt Therapeutics, Inc. [RAPT] share price is $57.72. The Score for RAPT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
RAPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Rapt Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Rapt Therapeutics, Inc. has on average historically risen by 70.3% based on the past 6 years of stock performance.
Rapt Therapeutics, Inc. Stock Rating
Sell
47
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. overpriced?
-
Rapt Therapeutics, Inc. has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Rapt Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
rapt.com
52-Week Data
52-Week High:
57.86
52-Week Low:
5.67
Prediction Charts
Market Cap:
954.6M
Price in USD:
57.72
Volume:
12.1M
Beta:
0.33
Technical Analysis
SMA50:
43.01
SMA100:
35.92
SMA200:
23.03
52-Wk Change:
506.3%
Stock Predictions
-
Is Rapt Therapeutics, Inc. stock public?Yes, Rapt Therapeutics, Inc. is a publicly traded company.
-
What is the Rapt Therapeutics, Inc. stock quote today?The Rapt Therapeutics, Inc. stock price is 57.72 USD today.
-
How to buy Rapt Therapeutics, Inc. stock online?You can buy Rapt Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-27 | 57.65 | 57.61 | 57.66 | 57.57 |
| Jan-28 | 57.65 | 57.65 | 57.70 | 57.60 |
| Jan-29 | 57.67 | 57.63 | 57.69 | 57.59 |
| Jan-30 | 57.64 | 57.68 | 57.80 | 57.63 |
| Feb-2 | 57.71 | 57.68 | 57.77 | 57.64 |
| Feb-3 | 57.70 | 57.75 | 57.79 | 57.65 |
| Feb-4 | 57.73 | 57.78 | 57.86 | 57.61 |
| Feb-5 | 57.73 | 57.68 | 57.76 | 57.64 |
| Feb-6 | 57.70 | 57.69 | 57.80 | 57.64 |
| Feb-9 | 57.71 | 57.77 | 57.80 | 57.69 |
| Feb-10 | 57.78 | 57.74 | 57.80 | 57.69 |
| Feb-11 | 57.76 | 57.72 | 57.81 | 57.71 |
| Feb-12 | 57.74 | 57.82 | 57.82 | 57.73 |
| Feb-13 | 57.82 | 57.72 | 57.82 | 57.71 |
Rapt Therapeutics, Inc. Earnings
Rapt Therapeutics, Inc. Earnings Report: Per Share Rapt Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Rapt Therapeutics, Inc. Forecast Revenue Growth
Rapt Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Rapt Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $1.58 per share.
* Rapt Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.